Hanover - Delayed Quote EUR
Tilray Brands Inc (2HQ.HA)
0.4378
+0.0477
+(12.23%)
At close: April 25 at 5:25:31 PM GMT+2
Loading Chart for 2HQ.HA
- Previous Close
0.3901 - Open
0.4689 - Bid 0.4227 x --
- Ask 0.4337 x --
- Day's Range
0.4378 - 0.4689 - 52 Week Range
0.3803 - 1.9930 - Volume
0 - Avg. Volume
50 - Market Cap (intraday)
-- - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Apr 8, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 2HQ.HA
View MorePerformance Overview: 2HQ.HA
Trailing total returns as of 4/25/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
2HQ.HA
67.68%
S&P 500 (^GSPC)
6.06%
1-Year Return
2HQ.HA
73.63%
S&P 500 (^GSPC)
9.44%
3-Year Return
2HQ.HA
90.94%
S&P 500 (^GSPC)
28.61%
5-Year Return
2HQ.HA
90.22%
S&P 500 (^GSPC)
94.77%
Compare To: 2HQ.HA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
0.4378
+12.23%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.9360
-0.74%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.4940
+37.22%
Mkt Cap EUR 201.371M
Industry Drug Manufacturers—Specialty & Generic
3.7400
0.00%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
2.9200
0.00%
Mkt Cap EUR 340.492M
Industry Drug Manufacturers—Specialty & Generic
3.8920
-4.89%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
1.3920
+26.78%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.6150
+21.78%
Mkt Cap EUR -
Industry Drug Manufacturers—Specialty & Generic
0.9350
-0.74%
Mkt Cap EUR 125.083M
Industry Drug Manufacturers—Specialty & Generic
Statistics: 2HQ.HA
View MoreValuation Measures
As of 4/25/2025
Market Cap
428.72M
Enterprise Value
513.04M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.51
Price/Book (mrq)
0.18
Enterprise Value/Revenue
0.70
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--